Fetal genes

Details Fetal genes Fetal genes

2011-04-05

2011-04-05

Kim, Alexander D (Department: 1656)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S071100, C435S006120

Reexamination Certificate

active

07919604

ABSTRACT:
Novel fetal genes (fls353 and fls485) have been successfully isolated from human fetal liver-derived cDNAs. These genes were specifically expressed in tissues including fetal tissues which are thought to contain a large number of undifferentiated cells and actively differentiating/proliferating cells. High levels of expression of these genes were observed also in a variety of cancer cells. The proteins and genes encoding the proteins can be used as the tool for developing drugs for the treatment of tumors.

REFERENCES:
patent: 2002/0115599 (2002-08-01), Vernos et al.
patent: 0736543 (1996-10-01), None
patent: WO 99/04265 (1999-01-01), None
patent: WO 99/37788 (1999-07-01), None
patent: WO 00/60071 (2000-10-01), None
patent: WO 01/57058 (2001-08-01), None
Katzav et al., Vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells, The EMBO Journal, 1989, vol. 8, pp. 2283-2290.
Transformation definition by Marriam-Webster (last viewed on Sep. 29, 2009).
Laity et al., Zinc finger proteins: new insights into structural and functional diversity, 2001, vol. 11, pp. 39-46.
Ambrosini, G., et al. (1997). A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma. Nat Med. 3(8):917-921.
Bischoff, J.R., et al. (1998). A homologue ofdrosophila aurorakinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17(11):3052-3065.
Frahm, S.O., et al. (1999). Immunoenzymatic detection of the new proliferation associated protein p100 by means of a cellular ELISA: specific detection of cells in cell cycle phases S, G2 and M. J Immunol Methods. 223(2):147-153.
Geneseq Accession No. AAX40161; available Jul. 2, 1999.
Heidebrecht et al. (1997) Blood, vol. 90, pp. 226-233.
Hufton, S.E., et al. (1999). A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett. 463(1-2):77-82.
Manda, R., et al. (1999). Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display. Genomics. 61(1):5-14.
NCBI report of NP—036244 with gi: 20127519 (originally created in Oct. 26, 2000).
Nezu, J. Fetal gene preferentially expressed in colorectal cancer. Database Embl Online!, Database accession No. AB024704, Apr. 20, 1999.
Su, L., et al. (1993). LYAR, a novel nucleolar protein with zinc finger DNA-binding motifs, is involved in cell growth regulation. Genes Dev. 7(5):735-748.
Tamai, I., et al. (1997). Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 419(1):107-111.
Wittmann, T., et al. (2000). TPX2, A novelxenopusMAP involved in spindle pole organization. J Cell Biol. 149(7):1405-1418.
Zhang, Y., et al. (1999). Assignment of human proliferation associated p100 gene (C20orf1) to human chromosome band 20q11.2 by in situ hybridization. Cytogenet Cell Genet. 84(3-4):182-183.
Fish & Richardson P.C., Preliminary Amendment in U.S. Appl. No. 09/974,143, filed Jan. 7, 2002 (4 pages).
Restriction Requirement, in U.S. Appl. No. 09/974,143, mailed Sep. 26, 2003 (12 pages).
Fish & Richardson P.C., Amendment and Response to Restriction Requirement mailed Sep. 26, 2003, in U.S. Appl. No. 09/974,143, filed Nov. 25, 2003 (8 pages).
Office Action, in U.S. Appl. No. 09/974,143, mailed Feb. 23, 2004 (20 pages).
Fish & Richardson P.C., Response to Office Action, mailed Feb. 23, 2004, in U.S. Appl. No. 09/974,143, filed Aug. 19, 2004 (18 pages).
Ex Parte Quayle Action, in U.S. Appl. No. 09/974,143, mailed Nov. 12, 2004 (11 pages).
Fish & Richardson P.C., Amendment in Reply to Office Action, mailed Nov. 12, 2004, in U.S. Appl. No. 09/974,143, filed Jan. 12, 2005 (10 pages).
Notice of Allowance, in U.S. Appl. No. 09/974,143, mailed Mar. 22, 2005 (7 pages).
Fish & Richardson P.C., Response to Notice of Allowance, mailed Nov. 12, 2004, in U.S. Appl. No. 09/974,143, filed Jun. 14, 2005 (2 pages).
Fish & Richardson P.C., Preliminary Amendment and Request for Transfer in Computer Readable Form, in U.S. Appl. No. 11/182,592, filed Jul. 14, 2005 (12 pages).
Restriction Requirement, in U.S. Appl. No. 11/182,592, mailed May 17, 2006 (7 pages).
Fish & Richardson P.C., Response to Restriction Requirement, mailed May 17, 2006, in U.S. Appl. No 11/182,592, filed Jun. 15, 2006 (6 pages).
Office Action, in U.S. Appl. No. 11/182,592, mailed Jul. 14, 2006 (17 pages).
Fish & Richardson P.C., Response to Office Action, mailed Jul. 14, 2006, in U.S. Appl. No. 11/182,592, filed Oct. 13, 2006 (7 pages).
Fish & Richardson P.C., Notice of Allowance, mailed Jan. 10, 2007, in U.S. Appl. No. 11/182,592 (10 pages).
Fish & Richardson P.C., Response to Notice of Allowance, mailed Jan. 10, 2007, in U.S. Appl. No. 11/182,592, filed Apr. 4, 2007 (2 pages).
EMBL Accession No. AA308814; Apr. 18, 1997.
EMBL Accession No. AB024705; Apr. 20, 1999.
Ikumi T. et al., “Cloning and characterization of a novel human pH-dependent organic cation transporter OCTN1”, FEBS Letters, Elsevier, Amsterdam, NL, vol. 419, No. 1, Jan. 1, 1997 (pp. 107-111).
Genbank Accession No. NM—012112. Downloaded from www.ncbi.nlm.nih.gov on Oct. 22, 2009.
Genbank Accession No. AA305159, Apr. 18, 1997. downloaded from www.ncbi.nlm.nih.gov/sviewer/viewer.fcgi?1957712:EET:946692.
Genbank Accession No. AI220429, Oct. 10, 1998. downloaded from www.ncbi.nlm.nih.gov/sviewer/viewer.fcgi?3802632:EST:199141.

Affiliated with

Also associated with

Rating

Fetal genes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fetal genes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fetal genes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2724357